venBio Partners — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
ImmPACT Bioimmpact-bio.comSeries B · Jan 2022 · $140M
Co-investorsDecheng CapitalForesite Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ceptur Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.